Literature DB >> 26294622

Characterization of Novel HIV-1 Intersubtype CRF01_AE/C and A1/C Recombinants from India.

Sudhanshu Shekhar Pandey1, Madhuri Thakar1, Ramesh Paranjape2.   

Abstract

We report here three novel HIV-1 intersubtype recombinants from India. One among those is a recombinant between subtype C and CRF01_AE and another two between A1 and C. A recombinant virus with CRF01_AE is reported for the first time from India.
Copyright © 2015 Pandey et al.

Entities:  

Year:  2015        PMID: 26294622      PMCID: PMC4543500          DOI: 10.1128/genomeA.00849-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Human immunodeficiency virus strains have shown extraordinary genetic diversity, as evidenced by 9 subtypes, >70 circulating recombinant forms (CRFs), and innumerable unique recombinant forms. Of these, subtype C is most prevalent in India, while subtypes A1, B, CRF01_AE, and CRF02_AG have occasionally been reported. Apart from these, A1/C (1, 2) and B/C (3) intersubtype recombinants have also occasionally been reported. Here, we report for the first time in India a unique HIV-1 recombinant between subtype C and CRF01_AE and two novel recombinants between subtype A1 and C. Unique recombinant forms (URFs) between CRF01_AE and subtype C have been reported from Myanmar, China, and Nepal (Los Alamos HIV Database). The recombinant strain NARI-FLS_VB5 was amplified using cocultured proviral DNA using a methodology described previously (4) and sequenced directly from the PCR product using the ABI Prism 3730XL DNA analyzer (Applied Biosystems). The near-full-length genome (NLFG) sequence was initially analyzed for recombination using RIP and for recombination breakpoints using jpHMM at Gobics and SimPlot. Breakpoints were further confirmed using phylogenetic analysis. Strain NARI-FLS_VB-5 showed an insertion of CRF01_AE at three sites, positions 5711 ± 9 to 5901 ± 8, 6025 ± 13 to 8380 ± 7, and 8868 ± 6 to 8978 ± 6 into the backbone of subtype C, whereas at positions 8380 ± 7 to 8593 ± 7, jpHMM showed uncertainty between subtype C and CRF01_AE. A bootscan analysis of NARI-FLS_VB-5 showed similar breakpoints to those of jpHMM, with two more small insertions of CRF01_AE at positions 2871 to 3050 and 4878 to 5013. Combining the results obtained with RIP (5), jpHMM (6), and SimPlot (1) suggests insertions of CRF 01_AE at five positions in the backbone of subtype C. Two of the strains, NARI-FLS_VB27 and NARI-FLS_IVC3, have been cloned and sequenced using a methodology described previously (4). NARI-FLS_VB27 and NARI-FLS_IVC3-1 showed recombination of subtype A1 into the backbone of subtype C. Both clones of NARI-FLS_IVC3-1 showed an insertion of subtype A1 into the backbone of subtype C in pol (positions 3508 ± 17 to 4033 ± 35) and nef-LTR (positions 8578 ± 9 to 9632). Of the 11 clones generated for NARI-FLS_VB27, six clones showed two small insertions of subtype A1 into the backbone of subtype C int-vif (positions 4826 ± 84 to 5162 ± 10 and 5368 ± 10 to 5570 ± 26); one clone showed slightly different breakpoints (positions 4826 ± 84 to 5202 ± 20 and 5455 ± 24 to 5570 ± 26), and four clones showed an insertion of subtype A1 at positions 4826 ± 84 to 5162 ± 10 and uncertainty between subtype A1 and C at positions 5436 ± 5 to 5583 ± 12. Phylogenetic analysis using a recombinant region from positions 5368 to 5583 formed a monophyletic cluster with bootstrap support of 100. The phylogenetic tree suggests that the uncertainty region may be a result of the evolution of the strain after the introduction into the subject. SimPlot analysis also showed breakpoints in concordance with jpHMM (6) for both strains. All the breakpoints used in the study were relative to the HXB2 genome. A comparison of the URFs characterized in this study with the earlier reported URF 01C and A1C recombinant forms suggest that all three characterized URFs are novel recombinants. The detection of an 01C recombinant also points to the fact that HIV viruses belonging to multiple subtypes are circulating and giving rise to new URFs. This clearly indicates that the HIV epidemic in India is still evolving and needs close monitoring.

Nucleotide sequence accession numbers.

The near-full-genome shotgun sequences are available in GenBank under the accession numbers KT175202 to KT175215.
  6 in total

1.  Evidence of a novel B/C recombinant exhibiting unique breakpoints of near full-length HIV type 1 genome from Northeastern India.

Authors:  Samir Lakhashe; Srikanth Tripathy; Ramesh Paranjape; Jayanta Bhattacharya
Journal:  AIDS Res Hum Retroviruses       Date:  2008-02       Impact factor: 2.205

2.  Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin.

Authors:  Samir Lakhashe; Srikanth Tripathy; Ramesh Paranjape; Jayanta Bhattacharya
Journal:  AIDS Res Hum Retroviruses       Date:  2008-01       Impact factor: 2.205

3.  Molecular characterization of unique intersubtype HIV type 1 A1/C recombinant strain circulating in Pune, India.

Authors:  Sudhanshu Pandey; Srikanth Tripathy; Ramesh Paranjape
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-19       Impact factor: 2.205

4.  A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences.

Authors:  A C Siepel; A L Halpern; C Macken; B T Korber
Journal:  AIDS Res Hum Retroviruses       Date:  1995-11       Impact factor: 2.205

5.  Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.

Authors:  K S Lole; R C Bollinger; R S Paranjape; D Gadkari; S S Kulkarni; N G Novak; R Ingersoll; H W Sheppard; S C Ray
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

6.  jpHMM: recombination analysis in viruses with circular genomes such as the hepatitis B virus.

Authors:  Anne-Kathrin Schultz; Ingo Bulla; Mariama Abdou-Chekaraou; Emmanuel Gordien; Burkhard Morgenstern; Fabien Zoaulim; Paul Dény; Mario Stanke
Journal:  Nucleic Acids Res       Date:  2012-05-16       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.